drugset / Trial / NCT02349724
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The main purpose of this research is to verify the safety of CEA targeted chimeric antigen receptor T cells and to determine the proper dosage of CAR T cells infused.
Timeline
- Start
- 2014-12
- Primary completion
- 2018-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-CEA-CAR T | Cell therapy | — | — |